For most people, yes, the same antidepressant will work again if you restart it after a break. But it’s not guaranteed. Across multiple studies covering nearly 600 patients, between 4% and 57% of people who stopped a previously effective antidepressant found it didn’t work as well when they went back on it. A large systematic review pooling the data more precisely found that about 16.5% of patients experienced some degree of response failure after restarting, meaning roughly five out of six people did fine going back to their old medication.
That wide range reflects real differences in circumstances: how long you were off the medication, why you stopped, and the specific drug all play a role. Here’s what the research actually shows about your chances.
How Often Restarting Works
The numbers vary significantly depending on the study and the drug involved. In some trials, as few as 4% of people lost their response after restarting. In others, particularly one study of patients restarting from medical records rather than a controlled setting, the failure rate climbed to 43%. Most studies cluster in the 8% to 26% range, which means the majority of people who restart their antidepressant will respond to it again.
Drug type matters. In one study of patients restarting fluoxetine at 20 mg, 89% responded, though some of those responders didn’t maintain their improvement over six months. Patients restarting duloxetine at 60 mg saw a 74% response rate and 57% reached full remission. Older tricyclic antidepressants showed mixed results, with failure rates ranging from about 8% to 19% depending on the specific drug. One trial of patients restarting clomipramine, fluoxetine, fluvoxamine, or paroxetine found 16% had a weaker or completely ineffective response compared to their first time on the drug.
Why a Medication Might Not Work the Second Time
When an antidepressant stops working or fails on restart, the phenomenon is sometimes called antidepressant tachyphylaxis, or more colloquially, “poop-out.” The underlying biology isn’t fully understood, but the leading theory involves your brain adapting to the drug at a cellular level. Over time, the receptors that the medication targets can change in number or sensitivity. Essentially, your brain recalibrates itself around the drug’s effects, and after a break, that recalibration may mean the same dose no longer produces the same chemical result.
There’s also a subtler possibility that researchers have flagged. When you restart an antidepressant shortly after stopping, the initial improvement you feel might actually be the relief of withdrawal symptoms rather than a true antidepressant effect. One study observed that patients who had previously stopped fluoxetine abruptly were less likely to maintain their response over time after restarting, suggesting the short-term bounce-back was masking a reduced long-term benefit.
Your depression itself may also have changed. Each depressive episode can differ in its severity, triggers, and underlying biology. A medication that matched well with one episode’s profile may be a less precise fit for the next one, even if the surface-level symptoms feel identical to you.
How Stopping Method Affects Your Odds
Whether you tapered off gradually or stopped abruptly may influence how well the drug works when you go back. Among the studies reviewed, half involved patients who had no taper at all when they originally discontinued. The data isn’t robust enough to draw firm percentages, but the pattern researchers noted is concerning for abrupt stoppers: that fluoxetine study showing reduced long-term maintenance specifically involved patients who quit cold turkey.
The gap between stopping and restarting also varied enormously across studies, from as little as 5 days to more than 2 years. No study has cleanly isolated the effect of gap length on restart success, but longer gaps mean more time for your brain chemistry to shift away from its medicated baseline, which could theoretically cut either way. Your brain might “reset” and respond freshly, or it might settle into a new equilibrium that the drug can’t easily disrupt again.
When a Higher Dose Helps
If the same dose doesn’t produce the same results, increasing the dose is often the first adjustment tried. In one study of patients who relapsed while still on fluoxetine, bumping up the dose led to a response in 57% to 72% of cases, depending on the formulation. That’s encouraging, but it also means roughly a third of patients didn’t respond even at a higher dose, and some who initially improved on the increase eventually relapsed again. About 35% of patients in that study either never responded to the dose increase or responded briefly and then lost ground.
This suggests that a dose bump is worth trying as a first move, but it’s not a universal fix. If the underlying issue is receptor-level adaptation, a higher dose may temporarily overcome the tolerance, but the same adaptation process can continue.
What to Do if It Doesn’t Work
If restarting your previous antidepressant doesn’t produce the results you remember, the main options are switching to a different antidepressant or adding therapy. APA guidelines for patients who don’t respond to an antidepressant recommend either switching to a different medication or switching to cognitive therapy. There isn’t strong evidence showing that any one second-choice antidepressant outperforms another, so the decision typically comes down to side effect profiles and what classes you haven’t tried.
For people who do achieve remission again, whether on the restarted drug or a new one, adding psychotherapy like cognitive-behavioral therapy or mindfulness-based cognitive therapy can help prevent another relapse down the line. The APA specifically recommends therapy over medication alone for long-term relapse prevention, which is worth considering if you’ve now been through more than one depressive episode.
The Realistic Picture
The odds are in your favor. Most people who restart a previously effective antidepressant will respond to it again. But “most” isn’t “all,” and the 16.5% average failure rate means this is a real possibility, not a rare fluke. The risk appears higher if you stopped abruptly, if you’ve had multiple depressive episodes, or if a significant amount of time has passed. If the medication does fall short, a dose increase works for a majority of people as a next step, and switching drugs or adding therapy remain solid options after that. Going back to what worked before is a reasonable first move, just not a certainty.